- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Clinical Trials in New Zealand
Total 8312 results
-
Rutgers, The State University of New JerseyPfizer; American Cancer Society, Inc.CompletedImmunotherapy | Clinical TrialsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); Pediatric Brain Tumor ConsortiumActive, not recruitingAccurate and Complete Data Acquisition for Clinical TrialsUnited States
-
University of New MexicoNational Center for Research Resources (NCRR)TerminatedPregnancy | Randomized Clinical Trial | Docosahexaenoic AcidUnited States
-
AuriGen Medical LtdRecruiting
-
Wellington HospitalRecruitingAtrial FibrillationNew Zealand
-
University of Auckland, New ZealandCompletedGynecologic CancerNew Zealand
-
Australian and New Zealand Intensive Care Research...Intensive Care Foundation, AustraliaCompletedCritically Ill Adults Ventilated >24 Hours in Intensive CareAustralia, New Zealand
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Australian and New Zealand Intensive Care Research...Baxter Healthcare CorporationCompletedCritical Illness | Multiple Organ FailureAustralia, New Zealand
-
Australian and New Zealand Intensive Care Research...Completed
-
Hoffmann-La RocheCompleted
-
Bardy Diagnostics, Inc.UnknownAtrial Fibrillation | Syncope | Supraventricular Tachycardia | Presyncope | PalpitationsNew Zealand
-
Trans Tasman Radiation Oncology GroupFisher and Paykel Healthcare; Auckland City HospitalCompletedCancer of the Head and NeckNew Zealand
-
Middlemore Hospital, New ZealandUnknown
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau HealthCompletedColorectal Cancer | Surgery | Perioperative Care | ColectomyNew Zealand
-
Provectus PharmaceuticalsCompleted
-
Boston Scientific CorporationCryterion Medical, Inc.Completed
-
Australian and New Zealand Intensive Care Research...Australian and New Zealand Intensive Care Society Clinical Trials GroupCompletedCritically IllAustralia, New Zealand
-
Hoffmann-La RocheCompleted
-
AmgenCompletedAny Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical TrialCanada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
-
National Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric... and other conditionsUnited States
-
Targovax ASATerminated
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
BayerCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Cagent Vascular LLCCompletedPeripheral Arterial Disease | Critical Limb IschemiaNew Zealand, Austria, Germany, Poland
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Australian and New Zealand Intensive Care Research...Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaboratorsCompletedSepsis | Shock, Septic | Critically Ill | Vasoplegic SyndromeAustralia, New Zealand, Brazil
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials GroupCompletedCancerAustralia, New Zealand
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
SynCore Biotechnology Co., Ltd.Suspended
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Zealand University HospitalUnknownHematological CancerDenmark
-
Cinfa BiotechCompletedClinical PharmacologyGermany
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Refractory Triple-Negative Breast CarcinomaUnited States
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical CenterCompletedBreast Cancer | Metastatic Triple NegativeUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCCUnited States
-
BayerCompleted
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
Zealand University HospitalVejle Hospital; University Hospital Schleswig-Holstein; University College AbsalonActive, not recruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast CarcinomaUnited States
-
Philips HealthcareYale UniversityCompletedClinical AlarmsUnited States